Joel M. Gelfand
- Dermatology top 0.01%
- Dermatology and Skin Diseases 92
- Cutaneous lymphoproliferative disorders research 18
- Immunology top 0.05%
- Psoriasis: Treatment and Pathogenesis 159
- Complementary and Manual Therapy top 0.1%
- Rheumatology top 0.05%
- Spondyloarthritis Studies and Treatments 43
- Rheumatoid Arthritis Research and Therapies 29
- Immunology and Allergy top 0.1%
- Allergic Rhinitis and Sensitization 27
-
- Health Systems, Economic Evaluations, Quality of Life 38
-
- Asthma and respiratory diseases 27
- Co-authors
- Daniel B. ShinDavid J. MargolisAndrea B. TroxelAndrea L. NeimannXingmei WangNehal N. MehtaAlexis OgdieShanu Kohli Kurd
- Partner nations
- United StatesUnited KingdomIceland
In The Last Decade
Joel M. Gelfand
267 papers receiving 21.0k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Dermatology 9.1k
- Immunology 14.3k
- Complementary and Manual Therapy 825
- Rheumatology 5.1k
- Immunology and Allergy 2.0k
Countries citing papers authored by Joel M. Gelfand
This map shows the geographic impact of Joel M. Gelfand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel M. Gelfand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel M. Gelfand more than expected).
Fields of papers citing papers by Joel M. Gelfand
This network shows the impact of papers produced by Joel M. Gelfand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel M. Gelfand. The network helps show where Joel M. Gelfand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joel M. Gelfand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 10 | |
| 9 | 2021 | 29 | |
| 10 | 2020 | 43 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 96 | |
| 13 | 2019 | 56 | |
| 14 | 2018 | 41 | |
| 15 | 2018 | 41 | |
| 16 | 2018 | 119 | |
| 17 | Patient burden and quality of life in atopic dermatitis in US adultsbreakdown → | 2018 | 445 |
| 18 | 2015 | 164 | |
| 19 | Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort studybreakdown → | 2014 | 354 |
| 20 | Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors | 2012 | 2 |
About Joel M. Gelfand
Joel M. Gelfand is a scholar working on Dermatology, Immunology and Immunology and Allergy, having authored 283 papers that have together received 21.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (159 papers), Dermatology and Skin Diseases (92 papers), Spondyloarthritis Studies and Treatments (43 papers), Health Systems, Economic Evaluations, Quality of Life (38 papers), Rheumatoid Arthritis Research and Therapies (29 papers), Allergic Rhinitis and Sensitization (27 papers), Asthma and respiratory diseases (27 papers) and Cutaneous lymphoproliferative disorders research (18 papers). The work is most often cited by research in Dermatology (9.1k citations), Immunology (14.3k citations) and Complementary and Manual Therapy (825 citations). Joel M. Gelfand has collaborated with scholars based in United States, United Kingdom and Iceland. Frequent co-authors include Daniel B. Shin, David J. Margolis, Andrea B. Troxel, Andrea L. Neimann, Xingmei Wang, Nehal N. Mehta, Alexis Ogdie, Shanu Kohli Kurd, Rahat S. Azfar and Junko Takeshita. Their work appears in journals such as JAMA, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.